Trial intelligence / Profile preview

Tetracycline Dosing in H. pylori Rescue Therapy

NCT05802888Phase 4Unknown

Sponsor
Shandong University
Start
Mar 2023
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tetracycline in Helicobacter pylori infection, sponsored by Shandong University. Status: unknown.

02

Drugs

tetracycline
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT05802888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05802888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call